ARTICLE

FindCenter AddIcon

World-First Clinical Trial Explores Safety and Efficacy of DMT for Major Depression

By Ruairi J. Mackenzie — 2020

The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read on www.technologynetworks.com

FindCenter Post-Image

Rapid Antidepressant Effects of the Psychedelic Ayahuasca Linked to Changes in Inflammatory Biomarkers

The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.

Article
Eric W. Dolan
2021
FindCenter AddIcon
FindCenter Post-Image

The Autoimmune Spectrum: Does It Exist, and Are You on It?

Autoimmunity—which affects three quarters more women than it does men—encompasses a range of conditions and diseases that involve the immune system mistakenly attacking the body’s own organs, tissues, and cells.

Article
goop Staff
FindCenter AddIcon

EXPLORE TOPIC

DMT